No results for ‘’
Supriya Lifescience Ltd
₹932.20
(0.01%)
Wed, 24 Jun 2026, 08:42 pm
Health Technology
Pharmaceuticals: Major
24.5KSupriya Lifescience Enterprise Value (EV)
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 26.13 | 17.08 | 22.42 | 31.41 |
| Price to book ratio | 0 | 0 | 0 | 0 | 6.44 | 2.19 | 3.27 | 5.92 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 7.63 | 3.41 | 4.79 | 8.69 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 75.98 | 21.14 | 21.65 | 34.21 |
| Enterprise value | 0 | 0 | 0 | 0 | 3767Cr | 1400Cr | 2601Cr | 5830Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 17.89 | 10.99 | 15.35 | 22.85 |
| Debt to equity ratio | 2.39 | 0.98 | 0.57 | 0.27 | 0.04 | 0.03 | 0.01 | 0.01 |
| Return on equity % | 0 | 53.11 | 60.40 | 59.17 | 34.34 | 13.66 | 15.73 | 20.74 |
Supriya Lifescience Ltd Enterprise Value
The Supriya Lifescience Ltd Enterprise Value is a key financial metric used by investors to evaluate Supriya Lifescience Ltd's valuation, profitability, and overall financial performance. Tracking the Supriya Lifescience Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Supriya Lifescience Ltd (NSE: SUPRIYA, BSE: 543434) is currently trading at ₹932.20, with a market capitalization of ₹7493.75Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Supriya Lifescience Ltd Enterprise Value is essential for fundamental analysis.
Supriya Lifescience Ltd Enterprise Value Current Value
The current Supriya Lifescience Ltd Enterprise Value stands at 5830Cr.
The latest Supriya Lifescience Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Supriya Lifescience Ltd Enterprise Value Historical Trend
The Supriya Lifescience Ltd Enterprise Value has shown the following historical trend:
- 2024: 5830Cr
- 2023: 2601Cr
- 2022: 1400Cr
- 2021: 3767Cr
- 2020: 0
The recent rise in Supriya Lifescience Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Supriya Lifescience Ltd Enterprise Value Indicates for Investors
The Supriya Lifescience Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Supriya Lifescience Ltd.
Supriya Lifescience Ltd Enterprise Value Analysis Summary
The Supriya Lifescience Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Supriya Lifescience Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Supriya Lifescience Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.